[1]
C. Ucciferri, A. Di Gasbarro, J. Vecchiet, and K. Falasca, “Efficacy and safety of deflazacort in diabetic subjects infected with SARS-CoV-2”, Multidiscip Respir Med, vol. 20, Oct. 2025, doi: 10.5826/mrm.2025.1035.